article thumbnail

Sudafed Dosage, Uses, and Side Effects

BuzzRx

Keeping Sudafed products behind the counter, along with other regulations, was mandated by the FDA in 2006 because pseudoephedrine, the main ingredient in Sudafed products, can be used illegally to make methamphetamine. Read the package label carefully to check the right product and dosage for your child.

Dosage 52
article thumbnail

Can you take Excedrin and ibuprofen together?

The Checkup by Singlecare

A study published in 2006 found that Excedrin’s combination of active ingredients worked better and faster than ibuprofen in treating migraine headaches. If you are taking other medications containing acetaminophen, you’ll need to calculate your total daily dosage when taking Excedrin to ensure you’re not overmedicating.

Dosage 52
Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

FDA’s Proposal to Remove Oral Phenylephrine from the OTC Monograph Isn’t a Surprise but What is Left “Over-the-Counter”?

The FDA Law Blog

As those of us of a certain age remember, prior to 2005/2006, pseudoephedrine was the decongestant of choice for OTC multi-symptom cold medicine. As dictated by the process provided for in the 2020 CARES Act, FDA announced issuance of the proposed order in a Federal Register notice and published the proposed order itself on FDA’s website.

FDA 108
article thumbnail

Securing every dose with an edible security technology for safe medicines

European Pharmaceutical Review

On- or in-dose authentication means that a security measure or anticounterfeit feature is integrated with the dosage form itself, offering product verification and traceability embedded into each medicine, rather than on the secondary package” WHO estimates that >50 percent of the drugs for sale on the internet are fake. References.

Dosage 98
article thumbnail

2022 spells change for EU pharmaceutical legislation

European Pharmaceutical Review

Regulation (EC) No 1901/2006 of the European Parliament and of the Council of 12 December 2006 on medicinal products for paediatric use and amending Regulation (EEC) No 1768/92, Directive 2001/20/EC, Directive 2001/83/EC and Regulation (EC) No 726/2004 (Text with EEA relevance). Future outlook. Amsterdam: Gupta Strategists; 2019.

article thumbnail

From Healing to Harm: The Unintended Consequences of Polypharmacy in Seniors

PharmD Live

Medication Non-Adherence Polypharmacy increases the likelihood of medication non-adherence due to the complexity and confusion of managing multiple medications.Patients often struggle with the regimen, missing doses, taking incorrect dosages, or discontinuing medications altogether, which can lead to suboptimal treatment results.

Hospitals 119
article thumbnail

Learning from lecanemab: a breakthrough treatment

European Pharmaceutical Review

At Eisai, we believe that the most important factors for successful clinical trials are the four R’s: Right Hypothesis, Right Population, Right Dosage and Right Endpoint. Since 2006, he has held leadership positions in the neuroscience area at Eli Lilly and in epidemiology at GlaxoSmithKline.

Dosage 96